Bradley M Haverkos

10PUBLICATIONS
105CO-AUTHORS
Liquid biopsiesHaematological tumoursPredictive and prognostic markersMolecular targetsImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Aug 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.

Narendranath Epperla, Adam S Zayac, Daniel J Landsburg

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|Aug 02, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.

Bradley Haverkos, Onder Alpdogan, Robert Baiocchi

|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

Adam S Zayac, Daniel J Landsburg, Mitchell E Hughes

|Apr 07, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.

Ajay Major, Jovian Yu, Navika Shukla

Pageof 2

Frequent Collaborators

4 joint publications

Reem Karmali

3 joint publications

Adam Zayac

3 joint publications

Narendranath Epperla

3 joint publications

Adam J Olszewski